The B cell in atherosclerosis: Teaming up with the bad guys?

Clinical Chemistry

Volumn 56, Issue 12, 2010, Pages 1789-1791

  Nilsson, Jan ^a   Fredrikson, Gunilla Nordin ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MALMÖ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; FC RECEPTOR IIB;

ANTIBODY PRODUCTION; ATHEROGENESIS; ATHEROSCLEROSIS; B LYMPHOCYTE; CHOLESTEROL BLOOD LEVEL; DISEASE COURSE; INFLAMMATION; LYMPHOCYTE FUNCTION; NONHUMAN; PROTEIN FUNCTION; SHORT SURVEY;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, NEUTRALIZING; ANTIGENS, CD20; APOLIPOPROTEINS E; ATHEROSCLEROSIS; AUTOIMMUNITY; B-LYMPHOCYTES; HUMANS; INFLAMMATION; INTERFERON-GAMMA; INTERLEUKIN-17; MICE; RECEPTORS, LDL; T-LYMPHOCYTES;

EID: 78649854017     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2010.153783     Document Type: Short Survey

References (5)

1. Hansson GK, Libby P. The immune response in atherosclerosis: a double-edged sword. Nat Rev Immunol 2006;6:508-19.
2. Ait-Oufella H, Herbin O, Bouaziz JD, Binder CJ, Uyttenhove C, Laurans L, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010;207:1579-87.
3. Tsimikas S, Brilakis ES, Lennon RJ, Miler ER, Witztum JL, McConnell JP, et al. Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events. J Lipid Res 2007;48: 425-33.
4. -/- mice. J Am Coll Cardiol 2007;50:2313-8.
5. Nilsson J, Fredrikson GN, Bjorkbacka H, Chyu KY, Shah PK. Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease. J Intern Med 2009;266: 221-31.